GE HealthCare partners with Duke Health and Queen’s to develop AI hospital operations software

CHICAGO - GE HealthCare (NASDAQ:GEHC), a prominent player in the Healthcare Equipment & Supplies industry with a market capitalization of $34.4 billion, announced collaborations with The Queen’s Health Systems and Duke Health to develop a new AI-driven hospital operations software solution, according to a company press release. InvestingPro analysis shows the company maintains a strong financial health score of "GOOD."

The forthcoming cloud-based Software as a Service solution will be part of GE HealthCare’s CareIntellect family of applications. The software will utilize AI and predictive analytics to recommend actions to hospital leaders, aiming to improve quality of care, patient flow, and resource allocation. With annual revenue of nearly $20 billion and EBITDA of $3.7 billion, GE HealthCare demonstrates substantial operational scale to support such technological initiatives.

The Queen’s Health Systems, a current user of GE HealthCare’s Command Center software, reported a 22.2% increase in patient transfer admissions and a 41.2% decrease in emergency department length of stay after implementing the existing technology.

"We have seen firsthand how data-driven insights are helping us better advance our mission to deliver the best care in the best possible way," said Ashley Shearer, Vice President at The Queen’s Medical Center.

The new solution draws on insights from nearly 500 hospitals using Command Center across 55,000 beds globally. It will run on GE HealthCare’s CareIntellect cloud infrastructure, designed to enable healthcare systems to deploy applications with enterprise-grade security and standard connections to electronic medical records.

The development comes as hospitals face growing patient volumes, staff shortages, and rising costs. According to data cited in the release, health systems’ expenses rose 6% year-over-year in 2024, including a 5% increase in staff expenses. InvestingPro data reveals GE HealthCare trades at an attractive valuation relative to its growth potential, with additional insights available in the comprehensive Pro Research Report, part of InvestingPro’s coverage of over 1,400 US stocks.

Bree Bush, General Manager of Command Center at GE HealthCare, said the company is "continuously innovating and working closely with customers to advance what’s possible with cloud, AI, and software solutions."

The collaboration aims to address operational challenges in healthcare delivery through technology-enabled solutions based on frontline expertise from the participating health systems. Investors anticipating the company’s next earnings report on October 30, 2025, can access detailed financial analysis and additional ProTips through InvestingPro’s comprehensive research platform.

In other recent news, GE HealthCare announced the launch of CareIntellect for Perinatal, a cloud-based application aimed at improving maternal and fetal care by integrating various clinical data. The company has also updated its Intelligent Radiation Therapy software, significantly reducing the time between cancer diagnosis and treatment from seven days to seven minutes for early adopters. In a strategic move, GE HealthCare entered an exclusive licensing agreement with Lantheus Holdings to develop and commercialize a prostate cancer diagnostic imaging agent in Japan. Additionally, GE HealthCare declared a quarterly dividend of $0.035 per share, payable in November 2025. However, the company is facing scrutiny as the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, impacting several major manufacturers, including GE HealthCare. Despite these challenges, the company continues to focus on innovation and strategic partnerships to enhance its product offerings and market reach.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.